Brainsway Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Brainsway Ltd., a foreign private issuer, on January 10, 2024, covering the month of January 2024. The company is headquartered in Jerusalem, Israel, and operates in the medical technology sector.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure rather than a financial statement.
Material Changes
The primary material event disclosed is the initiation of a clinical evaluation for the company's "Deep TMS 360" technology, which utilizes rotational field technology. No financial changes versus prior periods are reported in this document.
Outlook, Risks, and Management Commentary
Management has announced the start of clinical trials for the Deep TMS 360 system. The filing does not contain specific forward-looking guidance, risk factors, or contingencies beyond the standard incorporation by reference into previous registration statements (Form S-8 and Form F-3).
Key Facts for Investor Verification
- Brainsway has initiated a clinical evaluation of its new "Deep TMS 360" rotational field technology.
- This filing serves to update investors on a specific operational milestone rather than financial performance.
- Investors should verify the scope and timeline of the Deep TMS 360 clinical trial in subsequent reports or press releases.
- Financial data for the period is not included in this specific Form 6-K.